By six months, people without diabetes had lost 11.8% of their body weight, compared to 7.2% for those with diabetes
Emerging evidence and recent advances Evidence continues to emerge regarding additional indications and benefits of GLP-1 medications, including effects on aging, dementia, Parkinsonism, wound healing, knee arthritis pain, auto-immune conditions, substance use, cancer prevention, and cardiac health
Then: Units on syringe = (Desired dose mg / Concentration) x 100
GLP-1 prescriptions grew from ~9M in Q4 2022 (source) to ~24M by Q4 2024 (source)
'An easy way to achieve this is to put in a much higher dose so people might consume much more than they believe they do.' Meanwhile, Professor Naveed Sattar, an expert in cardiometabolic medicine at the University of Glasgow, told MailOnline: 'While there may be a slight weight benefit, even so, it is nowhere near the impact of evidence based weight loss therapies
Afonina IS, Zhong Z, Karin M, Beyaert R